Role of micro RNAs in theRegulation of α-Synuclein Expression: A Systematic Review

被引:39
作者
Recasens, Ariadna [1 ,2 ]
Perier, Celine [3 ,4 ]
Sue, Carolyn M. [1 ,2 ]
机构
[1] Royal North Shore Hosp, Northern Sydney Local Hlth Dist, Kolling Inst, Dept Neurogenet, St Leonards, NSW, Australia
[2] Univ Sydney, Sydney Med Sch, Northern Clin Sch, Sydney, NSW, Australia
[3] Vall dHebron Res Inst, Neurodecenerat Dis Lab, Barcelona, Spain
[4] Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Barcelona, Spain
来源
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2016年 / 9卷
关键词
Parkinson's disease; alpha-synuclein; microRNA; gene expression; miRNA; gene regulation; MIDBRAIN DOPAMINE NEURONS; MIRNA-433; BINDING-SITE; PARKINSONS-DISEASE; UP-REGULATION; MEDIATED AUTOPHAGY; SUBSTANTIA-NIGRA; GENE DUPLICATION; NONCODING RNAS; CELL-DEATH; CSP-ALPHA;
D O I
10.3389/fnmol.2016.00128
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Growing evidence suggests that increased levels of alpha-synuclein might contribute to the pathogenesis of Parkinson's disease (PD) and therefore, it is crucial to understand the mechanisms underlying alpha-synuclein expression. Recently, microRNAs (miRNAs) have emerged as key regulators of gene expression involved in several diseases such as PD and other neurodegenerative disorders. A systematic literature search was performed here to identify microRNAs that directly or indirectly impact in alpha-synuclein expression/accumulation and describe its mechanism of action. A total of 27 studies were incorporated in the review article showing evidences that six microRNAs directly bind and regulate alpha-synuclein expression while several miRNAs impact on alpha-synuclein expression indirectly by targeting other genes. In turn, alpha-synuclein overexpression also impacts miRNAs expression, indicating the complex network between miRNAs and alpha-synuclein. From the current knowledge on the central role of alpha-synuclein in PD pathogenesis/progression, miRNAs are likely to play a crucial role at different stages of PD and might potentially be considered as new PD therapeutic approaches.
引用
收藏
页数:12
相关论文
共 86 条
  • [51] Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons
    Mazzulli, Joseph R.
    Zunke, Friederike
    Tsunemi, Taiji
    Toker, Nicholas J.
    Jeon, Sohee
    Burbulla, Lena F.
    Patnaik, Samarjit
    Sidransky, Ellen
    Marugan, Juan J.
    Sue, Carolyn M.
    Krainc, Dimitri
    [J]. JOURNAL OF NEUROSCIENCE, 2016, 36 (29) : 7693 - 7706
  • [52] Mechanisms of gene silencing by double-stranded RNA
    Meister, G
    Tuschl, T
    [J]. NATURE, 2004, 431 (7006) : 343 - 349
  • [53] Upregulation of a small vault RNA (svtRNA2-1a) is an early event in parkinson disease and induces neuronal dysfunction
    Minones-Moyano, Elena
    Friedlaender, Marc R.
    Pallares, Joan
    Kagerbauer, Birgit
    Porta, Silvia
    Escaramis, Georgia
    Ferrer, Isidre
    Estivill, Xavier
    Marti, Eulalia
    [J]. RNA BIOLOGY, 2013, 10 (07) : 1093 - 1106
  • [54] Methodological challenges in utilizing miRNAs as circulating biomarkers
    Moldovan, Leni
    Batte, Kara E.
    Trgovcich, Joanne
    Wisler, Jon
    Marsh, Clay B.
    Piper, Melissa
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (03) : 371 - 390
  • [55] Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons
    Murphy, DD
    Rueter, SM
    Trojanowski, JQ
    Lee, VMY
    [J]. JOURNAL OF NEUROSCIENCE, 2000, 20 (09) : 3214 - 3220
  • [56] MIR-133b AMELIORATES AXON DEGENERATION INDUCED BY MPP+ VIA TARGETING RhoA
    Niu, M.
    Xu, R.
    Wang, J.
    Hou, B.
    Xie, A.
    [J]. NEUROSCIENCE, 2016, 325 : 39 - 49
  • [57] Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c
    Ohmachi, S
    Mikami, T
    Konishi, M
    Miyake, A
    Itoh, N
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 72 (04) : 436 - 443
  • [58] Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's Disease
    Parsi, Sepideh
    Smith, Pascal Y.
    Goupil, Claudia
    Dorval, Veronique
    Hebert, Sebastien S.
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2015, 4 : e256
  • [59] α-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
    Purisai, MG
    McCormack, AL
    Langston, WJ
    Johnston, LC
    Di Monte, DA
    [J]. NEUROBIOLOGY OF DISEASE, 2005, 20 (03) : 898 - 906
  • [60] Regulation of α-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons
    Rideout, HJ
    Dietrich, P
    Savalle, M
    Dauer, WT
    Stefanis, L
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 84 (04) : 803 - 813